P&G v. Amway
This article was originally published in The Tan Sheet
Houston federal judge Vanessa Gilmore rules P&G's Lanham Act claim that multi-level marketer disparaged Crest toothpaste is barred by Salt Lake City federal judge's earlier decision denying P&G's request to add product disparagement claims in a parallel lawsuit against Amway. In a Jan. 8 opinion, Gilmore also finds remaining P&G claims alleging Amway circulated false rumors that consumer products giant was associated with Satanism are similarly barred by res judicata effect of the Utah court's rulings, which were upheld by a Denver appeals court Jan. 6. P&G says it is "disappointed" in the rulings; Amway says court decisions end P&G's litigation against the company related to the Satanism rumors, with two cases still pending against Amway distributors...
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”